Table 1. TNBC patient characteristics.
Characteristic | Median (Range) |
---|---|
Age at Diagnosis (Years) (n=209) | 57 (30-91) |
Follow-Up (Months) | |
Recurrence Free Survival (n=199) | 38 (1-186) |
Metastasis Free Survival (n=200) | 40 (1-186) |
Breast Cancer Specific Survival (n=200) | 46 (1-186) |
N (%) | |
Tumor Grade | |
Grade 2 | 27 (13%) |
Grade 3 | 181 (87%) |
Unknown | 1 |
Histological Type | |
Ductal | 171 (82%) |
Lobular | 9 (4%) |
Metaplastic | 11 (5%) |
Mixed ductal | 2 (1%) |
Papillary | 1 (<0.5%) |
Medullary | 7 (3%) |
Apocrine | 6 (3%) |
Micropapillary | 1 (<0.5%) |
Unknown | 1 (<0.5%) |
Neoadjuvant Therapy | |
No | 183 (88%) |
Yes | 26 (12%) |
iNOS Levels | |
Negative | 28 (13%) |
Weak | 83 (40%) |
Moderate | 62 (30%) |
Strong | 36 (17%) |
Disease Free Survival* | |
No recurrence | 140 (70%) |
Recurrence | 59 (30%) |
Metastasis Free Survival* | |
No distant metastasis | 154 (77%) |
Distant Metastasis | 46 (23%) |
Breast Cancer Specific Survival** | |
Alive | 151 (75%) |
Deceased | 49 (25%) |
*9 patients excluded due to distant metastasis at diagnosis, and 1 treated in another country and lost to follow-up.
**9 patients excluded due to death from other causes.